# Alprostadil

## Promostan inj 20mcg

| TAH Drug Code      | [IPROM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPROM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Improvement of symptoms caused by peripheral arterial occlusive diseases. Maintenance of blood flow after vascular reconstructive surgery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Peripheral artery occlusive disease (POAD) adult: IVD, 2-3 vial (40-60 mcg) in NS 500 mL IVD > 2 hr. ( infusion rate: 5-10 ng/kg/min) once or twice daily (maximum: 0.6 mcg/kg/hr)                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Patients with severe heart failure or pulmonary edema. Patients with bleeding disorders (such as intracranial bleeding, hemorrhagic eye diseases, gastrointestinal bleeding, hemoptysis, etc., as it may increase the risk of bleeding). Pregnant women or women who may be pregnant (please refer to medication guidelines for pregnant women, postpartum women, breastfeeding women, etc.). Patients who have experienced allergic reactions to this medication.                                                                                                                                                              |
| Adverse Effects    | Common: Bradyarrhythmia (Neonates, 7%), Hypotension (Adult, up to 3% ; pediatric, 4%), Tachycardia (Neonates, 3%), Flushing (Neonates, 10%), Urethral discomfort (Adult, 12-13%), Pain in penis (Adult, 29-37%), Pain in testicle (Adult, 1-5%), Fever (Neonates, 14%) Serious: Cardiac arrest (Neonates, 1%), Gastrointestinal obstruction (Neonates, 6.8%), Disseminated intravascular coagulation (Neonates, 1%), Infantile cortical hyperostosis, Seizure (Neonates, 4%), Fibrosis of penis (Intracavernous, 3-7.8%), Priapism (Adult, less than 1%), Prolonged erection of penis (Adult, 0.3-4%), Apnea (Neonates, 10-12%) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/alprostadil-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

